Nanni-Zepeda, Melanni
Alizadeh, Sarah
Chand, Tara
Kasties, Vanessa
Fan, Yan
van der Meer, Johan
Herrmann, Luisa
Vester, Johannes C.
Schulz, Myron
Naschold, Britta
Walter, Martin
Clinical trials referenced in this document:
Documents that mention this clinical trial
Trait anxiety is related to Nx4’s efficacy on stress-induced changes in amygdala-centered resting state functional connectivity: a placebo-controlled cross-over trial in mildly to moderately stressed healthy volunteers
https://doi.org/10.1186/s12868-022-00754-4
Funding for this research was provided by:
Universitätsklinikum Jena
Article History
Received: 8 July 2022
Accepted: 10 November 2022
First Online: 24 November 2022
Change Date: 3 February 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s12868-023-00776-6
Declarations
:
: The study protocol has been approved by the local ethics committees of the university hospital Magdeburg and informed consent was obtained from all participants prior to the examination. The study was performed in accordance with ICH-GCP and the ethical standards as laid down in the Declaration of Helsinki.
: Not applicable.
: M.W. received institutional research support from Heel paid to his institution for this study, and from Brain-WaveBank and H. Lundbeck A/S outside the submitted work. The University of Tübingen received institutional fees for advisory services by Prof. Walter from Heel GmbH, Servier Deutschland GmbH, Bayer AG and Janssen-Cilag GmbH. The University of Tübingen received financial support for conference attendance of L.H. and M.L. from Heel for this study. J.C.V is a senior biometric consultant of idv Datenanalyse and Versuchsplanung (conceptualization, methodology, formal analysis, writing - original draft, writing - review and editing) and received personal fees for biometric services from the Foundation of the Society for the Study of Neuroprotection and Neuroplasticity (SSNN) out-side the submitted work, and idv Datenanalyse and Versuchsplanung received payments for biometric services from Heel, University Medical Center Göttigen, IgNova GmbH, Abnoba GmbH, AOP Orphan Pharmaceuticals AG, IDEA AG, PBB Entrepreneur Ltd, Tillots Pharma AG, STORZ Medical AG, EVER Neuro Pharma GmbH, MUCOS Pharma GmbH and Co. KG, Steigerwald Arzneimittelwerk GmbH outside the submitted work. M.S. and B.N. are employees of Heel GmbH. M.N.Z., S.A., T.C., V.K. Y.F. L.H. were part of M.W. team for this study, and declare no other conflict of interest outside the submitted work. All investigators followed the institutional guidelines for COI management in full compliance with the regulations of the Otto v. Guericke University, Magdeburg.